Sponsor Pipeline

Polish Myeloma Consortium Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-06 NCT07748689 Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and… Phase 2 Not Yet Recruiting
2026-07-31 NCT07740486 A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07740486 A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and… Multiple Myeloma (MM) Not Yet Recruiting
Phase 2
NCT07748689 Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and… Relapsed / Refractory Multiple Myeloma Not Yet Recruiting
Disease Areas
Multiple Myeloma (2)
Get alerts when Polish Myeloma Consortium's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free